Literature DB >> 12663161

In vitro evaluation of combination of terbinafine with itraconazole or amphotericin B against Zygomycota.

Alicia Gómez-López1, Manuel Cuenca-Estrella, Emilia Mellado, Juan L Rodríguez-Tudela.   

Abstract

The combined activity in vitro of amphotericin B/terbinafine and itraconazole/terbinafine was assessed against 17 clinical isolates of Zygomycota using a checkerboard technique. Itraconazole/terbinafine combination exhibited a potent synergistic effect against the most of strains. Amphotericin B/terbinafine combination showed an indifferent interaction for Rhizopus oryzae, and an additive effect for the other species.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12663161     DOI： 10.1016/s0732-8893(02)00509-6

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  12 in total

1.  Establishing a method of inoculum preparation for susceptibility testing of Trichophyton rubrum and Trichophyton mentagrophytes.

Authors:  D A Santos; M E S Barros; J S Hamdan
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

2.  In vitro interactions between antifungals and immunosuppressive drugs against zygomycetes.

Authors:  Eric Dannaoui; Patrick Schwarz; Olivier Lortholary
Journal:  Antimicrob Agents Chemother       Date:  2009-05-18       Impact factor: 5.191

3.  Terbinafine in combination with other antifungal agents for treatment of resistant or refractory mycoses: investigating optimal dosing regimens using a physiologically based pharmacokinetic model.

Authors:  Michael J Dolton; Vidya Perera; Lisa G Pont; Andrew J McLachlan
Journal:  Antimicrob Agents Chemother       Date:  2013-10-14       Impact factor: 5.191

4.  In vitro evaluation of the type of interaction obtained by the combination of terbinafine and itraconazole, voriconazole, or amphotericin B against dematiaceous molds.

Authors:  Fernanda Simas Corrêa Biancalana; Luzia Lyra; Angélica Zaninelli Schreiber
Journal:  Antimicrob Agents Chemother       Date:  2011-06-20       Impact factor: 5.191

5.  Drug combinations against Mucor irregularis in vitro.

Authors:  Shuzhen Zhang; Ruoyu Li; Jin Yu
Journal:  Antimicrob Agents Chemother       Date:  2013-04-15       Impact factor: 5.191

Review 6.  Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species.

Authors:  Marisa Z R Gomes; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

Review 7.  Combination treatment of invasive fungal infections.

Authors:  Pranab K Mukherjee; Daniel J Sheehan; Christopher A Hitchcock; Mahmoud A Ghannoum
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

8.  Dynamic interaction between fluconazole and amphotericin B against Cryptococcus gattii.

Authors:  Julliana Ribeiro Alves Santos; Ludmila Ferreira Gouveia; Erika Linzi Silva Taylor; Maria Aparecida Resende-Stoianoff; Gerson Antônio Pianetti; Isabela Costa César; Daniel Assis Santos
Journal:  Antimicrob Agents Chemother       Date:  2012-01-30       Impact factor: 5.191

9.  A case of relapsed chromoblastomycosis due to Fonsecaea monophora: antifungal susceptibility and phylogenetic analysis.

Authors:  Tatiane Caroline Daboit; Cibele Massotti Magagnin; Daiane Heidrich; Mauricio Ramírez Castrillón; Sandra Denise Camargo Mendes; Gerson Vettorato; Patrícia Valente; Maria Lúcia Scroferneker
Journal:  Mycopathologia       Date:  2013-05-04       Impact factor: 2.574

10.  Potential of Gallium as an Antifungal Agent.

Authors:  Rafael Wesley Bastos; Luana Rossato; Clara Valero; Katrien Lagrou; Arnaldo Lopes Colombo; Gustavo H Goldman
Journal:  Front Cell Infect Microbiol       Date:  2019-12-11       Impact factor: 5.293
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.